US Dollar vs Yen

登録してリアルタイムのチャート、分析ツール、価格を入手してください。

ホーム
投資
株式
オーストラリア
ASX
Paradigm Biopharmaceuticals Limited (PAROA) 銘柄情報

Paradigm Biopharmaceuticals Limited (PAROA)

0.001

0.00

(0.00%)

終了 7月3日 3:00PM

Paradigm Biopharmaceuticals Limited (PAROA) 銘柄情報

ポートフォリオを強化: リアルタイムのディスカッションと実用的な取引アイデア。

プレミアム

通貨

0.001

( - )

買値

0.001

売値

0.002

出来高

0.00

0.00 日の範囲 0.00

0.00 52 週間の範囲 0.00

時価総額

前日終値

0.001

始値

-

時刻

最終取引時間

財務取引量

-

VWAP

-

平均取引量 (3 か月)

AUD 2,222,887

発行済株式数

428,519,176

配当利回り

PER

-1.57

1 株当たり利益 (EPS)

-0.1

歳入

8.45k

純利益

-36.09M

Paradigm Biopharmaceuticals Limited engages in the research and development of therapeutic products for human use in Australia. Its lead candidate is Zilosul, an injectable pentosan polysulfate sodium drugs for the treatment of osteoarthritis, mucopolysaccharidosis, ross river virus, chikungunya vir... Paradigm Biopharmaceuticals Limited engages in the research and development of therapeutic products for human use in Australia. Its lead candidate is Zilosul, an injectable pentosan polysulfate sodium drugs for the treatment of osteoarthritis, mucopolysaccharidosis, ross river virus, chikungunya virus, chronic heart failure, allergic respiratory, and acute respiratory distress syndrome diseases. The company was incorporated in 2014 and is headquartered in Melbourne, Australia. 詳細を表示

セクター

-

業界

-

ウェブサイト

www.paradigmbiopharma.com

本社

Melbourne, Australia

設立

2026

Paradigm Biopharmaceuticals Limited is listed in the sector of the オーストラリア証券取引所 with ticker PAROA. The last closing price for Paradigm Biopharmaceutic... was AUD0. Over the last year, Paradigm Biopharmaceutic... shares have traded in a share price range of AUD 0.00 to AUD 0.00.

Paradigm Biopharmaceutic... currently has 428,519,176 shares in issue. The market capitalisation of Paradigm Biopharmaceutic... is AUD428,519.18 . Paradigm Biopharmaceutic... has a price to earnings ratio (PE ratio) of -1.57.

表示するニュースはありません。

期間 †	前日比	前日比 %	始値	高値	安値	平均出来高	VWAP
1	0	0	0	0	0	0	0	DE
4	0	0	0	0	0	0	0	DE
12	0	0	0	0	0	0	0	DE
26	0	0	0	0	0	0	0	DE
52	0	0	0	0	0	0	0	DE
156	0	0	0	0	0	0	0	DE
260	0	0	0	0	0	0	0	DE

PAROA - Frequently Asked Questions (FAQ)

What is the current Paradigm Biopharmaceuticals Limited share price?

The current share price of Paradigm Biopharmaceuticals Limited is AUD 0.001

How many Paradigm Biopharmaceuticals Limited shares are in issue?

Paradigm Biopharmaceuticals Limited has 428,519,176 shares in issue

What is the market cap of Paradigm Biopharmaceuticals Limited?

The market capitalisation of Paradigm Biopharmaceuticals Limited is AUD 428.52k

What is the 1 year trading range for Paradigm Biopharmaceuticals Limited share price?

Paradigm Biopharmaceuticals Limited has traded in the range of AUD 0.00 to AUD 0.00 during the past year

What is the PE ratio of Paradigm Biopharmaceuticals Limited?

The price to earnings ratio of Paradigm Biopharmaceuticals Limited is -1.57

What is the cash to sales ratio of Paradigm Biopharmaceuticals Limited?

The cash to sales ratio of Paradigm Biopharmaceuticals Limited is 10.26k

What is the registered address of Paradigm Biopharmaceuticals Limited?

The registered address for Paradigm Biopharmaceuticals Limited is 500 Collins Street, Melbourne, Victoria, 3000

What is the Paradigm Biopharmaceuticals Limited website address?

The website address for Paradigm Biopharmaceuticals Limited is www.paradigmbiopharma.com

FlashySage44

FlashySage44 10分前

Why would the stock disappear after a reverse split?
It would be reversing into strength.
It has great fundamentals. It’s a great defensive healthcare play.
Yes it would struggle at first due to reverse split aversion, but in the long term, it would be great for us.

ulmadi

ulmadi 20分前

Thanks for the correction.

Go NEWH

axelvento

axelvento 22分前

Trump’s Newly Disclosed Moderna Trades Preceded FDA Advisory Panel’s Unanimous Backing of mRNA Flu Vaccine

The filings show Trump purchased Moderna ($MRNA) on March 2 ($15,001-$50,000) and again on March 17 ($1,001-$15,000), before reporting a $1,001-$15,000 sale on May 18.
Mod

Methinks

Methinks 32分前

Likewise, buddy!

EZ2

Awesome ~~~~ great guy !! 🇺🇸

t1215s

t1215s 1時間前

I will address LOCH & LOCK BROKE aka Joseph Grimaldi & Emmett Kelly Monday 😉

To all enjoy our Nation’s 250th..Ts-🍻😎🇺🇸

Golfnut3

Golfnut3 1時間前

That's all I know, I saw it on one of the Facebook group pages...

AngeloFoca

AngeloFoca 1時間前

NWBO management, as I have said could engage in confidence building to help shareholders stay in but that would require them to care about the SP.

Linda is by far the largest shareholder, and all who work there, I'm sure, hold sizeable positions... But you think they don't care about

Seminole Red

Seminole Red 1時間前

Ruined VW’s - purist not allowed

Almost positive it’s ruined.

https://www.facebook.com/reel/1768850754281751

Ray_137

Ray_137 1時間前

Any news about the date of 30th June 2026?

SkeBallLarry

SkeBallLarry 2時間前

% Happy 4th to you, Getmore ~ Thanks 4 All % ..

OliXPharma_Official

OliXPharma_Official 2時間前

Global pharma interest in RNAi therapeutics continues to accelerate.

According to BioSpace, AstraZeneca has entered into a collaboration with CSPC Pharmaceutical Group to discover and develop siRNA therapeutics for kidney diseases. The deal is reportedly worth up to $1.77 billion, inc

Pittsburgh Boy

Pittsburgh Boy 2時間前

Umm no that's why I asked, thanks

diamondguru-one

diamondguru-one 2時間前

On September 30th…

President Trump is set to declare this miracle material a national strategic resource. And ban it as a U.S. expor t.

That means every major tech company on the planet will be forced to come here — to U.S. soil — to get it.

Apple, NVI

sentiment_stocks

sentiment_stocks 2時間前

If the mOS of the control arm drops, wouldn’t that increase the difference between the two?

I do wonder if the MAIC was, in the end, simply more conservative due to its weighting than the patient level scoring?

Kool Aid Man

Kool Aid Man 2時間前

Gullible goobers actually believe they'd own Patagroania..smh

BeachBum

BeachBum 2時間前

30 mil, pay attention.

europa7

europa7 2時間前

Europe's MiCA Deadline Leaves Four in Five Crypto Firms Without a Licence
1 July 2026
https://www.sandmark.com/news/features/europes-mica-deadline-leaves-four-five-crypto-firms-without-licence

"...The transitional window closed on 1 Jul, and the grace period that let nat

GseHeist

GseHeist 3時間前

Looks like AL4ZR is playing F2 soccer on the FiFA sidelines. Very very dangerous game he is playing and he doesn't belong here.

nowwhat2

nowwhat2 3時間前

https://investorshub.advfn.com/uimage/uploads/2026/7/3/ljz[qbtc_july_2_10y_10pm_GEE_200_60.jpg

https://investorshub.advfn.com/uimage/uploads/2026/7/3/qbfzqbtc_july_2_1y_200_60k_zoom.jpg

https://investorshub.advfn.com/uimage/uploads/2026/7

along4zride

along4zride 3時間前

He is in a league the garden variety penny pinching stock holder cannot comprehend. There is little empathy for (FNMA) bottom feeders.Never has been and never will be .

sometimes_right

sometimes_right 3時間前

The remaining bank defendants contesting LIBOR multi-billion-dollar appellate battle, along with those that have completely settled out of the primary investor tracks, are detailed below.

The Remaining Banks Involved in the Appeal
The specific financial institutions that did no

ZeroGravitas

ZeroGravitas 3時間前

JFB,
I know a lot of investors B&H QQQ but I think TQQQ is used more by traders. I know some that may go in and out of TQQQ based on the technical indicators for QQQ. I just think that there is a very small universe of investors with the stomach to hold on through a +70% drawdown. AIM will st

Paradigm Biopharmaceutic...

Centuria Capital

Metrics Income Opportuni...

Reach Resources Lld

Alicanto Minerals

Tribeca Global Natural R...

MetalsGrove Mining

Austco Healthcare

Cauldron Energy

Adavale Resources

Target Maturity Sept 202...

Delayed Upgrade Clock

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約

ADVFN

すでにアカウントをお持ちですか？サインイン

アカウントをお持ちでないですか？登録

登録することで、ADVFN の利用規約を読み、理解し、同意したこと、および私が個人投資家であることを確認します。